Our Story
Since our inception in 2015 in Denmark, Liva has been leading the way in the field of digital therapeutics. Our ambition is to prevent, manage and treat chronic disease through behaviour and lifestyle change, with a keen focus on cardiometabolic conditions. Over the years, we have expanded our reach across national healthcare systems and geographies, marking our presence as a global force for advancing health outcomes.
We integrate seamlessly into healthcare systems offering a unique hybrid digital therapeutics platform that combines personalised, one-on-one lifestyle coaching with innovative digital-first delivery.
Our team of dedicated healthcare professionals create tailored behaviour and lifestyle change programs to support patients in their journey to prevent, manage and treat obesity, type 2 diabetes, pre-diabetes and other cardiometabolic conditions. The safety and efficacy of our digital therapeutic programmes are well-supported by extensive evidence from randomised controlled trials (RCTs) and other clinical studies.
Headquartered in Copenhagen and London, Liva is at the forefront of delivering industry-leading lifestyle change and chronic disease management programmes across Europe. Our collaborations with healthcare systems, including the NHS, as well as partnerships with some of the world’s largest life science companies and health insurers allow us to impact lives on a large scale.
Executive Management
Shahram Sharif
CEO
Martin Paarse
COO & Deputy CEO
Karen O'Regan
CCO & UK GM
Sian Jarvis
Senior Advisor,
Communications & Marketing
Founders & Board of Directors
Michel Lussier
Chair
Rune Bech
Co-Founder
Carl Brandt
Co-Founder, Medical Director
Boris Bernstein
MIG, Munich
Guido Hegener
DHV, Berlin
Søren Hein
MIG, Munich
Kristoffer Pedersen
Maj Invest, Copenhagen
Latest news
Breakthrough Medications: Why Lifestyle Change Coaching is the Key to Success
Wegovy, the new weight-loss injection has become a household name. Worldwide demand for this new class of weight-loss medication known as GLP-1s containing semaglutide has grown rapidly since hitting the headlines. The drugs were previously developed to treat Type 2
Why gender, sex diversity, and representation matters in digital health
by Signe Bendsen Since the start of the COVID-19 pandemic, healthcare systems found themselves under immense pressure. The demand for innovative healthcare solutions has never
Finding ways to help people stay healthy through ageing
A new European research and innovation project studying healthy ageing launched this month. This collaborative project – of which Liva Healthcare is part – has
Sustainable Lifestyle Change: New Year’s Resolutions
written by Sian Jarvis, CMO For many of us the start of a new year provides the opportunity to reflect on life and to think